Live Geos: https://partners.subjectwell.com/publishers/geos_report/2768e681-87ca-4477-bca1-cf3c1f444ff5 Ages: 18+ Gender: All Compensation that can be listed: Compensation may be provided Study Description: This study is testing an investigational oral medication for asthma that is not well controlled despite treatment with inhaled corticosteroids. Participants will continue their usual asthma medications and also take two daily doses of either the study medication or a placebo for 6 months (24 weeks). Additional procedures include physical exams, vital signs, blood and urine testing, lung function testing, electrocardiograms (ECGs), and asthma and health questionnaires. Total participation will last approximately 8 months (32 weeks) and would include 9 office visits and 1 phone call with the study staff. Eligibility for the study will be determined by the study doctor following one or more in-person screening visits to the clinic. - Must be already diagnosed with asthma - Asthma diagnosis must have happened AT LEAST one year ago - Must have access to or be able to obtain documentation of your asthma diagnosis - Must use a corticosteroid inhaler (ICS) as your daily inhaler - Cannot also be diagnosed with cystic fibrosis, lung cancer, or COPD - No injectable biologic asthma medications in the last six months - No smoking in the last year

Vortex Alpha